Clinical Trial Update: Femoral Nerve Block With Bupivacaine and Adjuvant Dexamethasone in Patients With Hip Fracture [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating a femoral nerve block with bupivacaine and adjuvant dexamethasone in hip fracture patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fracture

Drugs mentioned

• Bupivacaine (Bupivacaine)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: University of Aarhus | Conditions: Hip Fracture | Phase 4 | Status: TERMINATED